We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

9th Circ. Vacates Drug Liability MDL Ruling Favoring Merck

Law360, New York (December 7, 2017, 3:46 PM EST) -- A Ninth Circuit panel on Wednesday vacated a win for Merck Sharp & Dohme Corp. and other drugmakers in a suit claiming that they failed to warn consumers about pancreas problems from Type 2 diabetes drugs, sending the class action back to the district court that the panel said erroneously interpreted a U.S. Supreme Court ruling.

In the unpublished unanimous decision, the panel agreed with the consumers that the California federal judge misread Buckman Co. v. Plaintiffs' Legal Committee — the high court decision that found...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Jean Adams v. Merck Sharp & Dohme Corp., et al


Case Number

15-56997

Court

Appellate - 9th Circuit

Nature of Suit

3367 Torts - Personal Injury

Date Filed

December 31, 2015

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.